These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 21235430)

  • 1. Developments in antivirals against influenza, smallpox and hemorrhagic fever viruses.
    Narayanan A; Bailey C; Kashanchi F; Kehn-Hall K
    Expert Opin Investig Drugs; 2011 Feb; 20(2):239-54. PubMed ID: 21235430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Clotrimazole Derivatives as Specific Inhibitors of Arenavirus Fusion.
    Torriani G; Trofimenko E; Mayor J; Fedeli C; Moreno H; Michel S; Heulot M; Chevalier N; Zimmer G; Shrestha N; Plattet P; Engler O; Rothenberger S; Widmann C; Kunz S
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30626681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic options for diseases due to potential viral agents of bioterrorism.
    Bronze MS; Greenfield RA
    Curr Opin Investig Drugs; 2003 Feb; 4(2):172-8. PubMed ID: 12669378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular approaches for the treatment of hemorrhagic fever virus infections.
    Andrei G; De Clercq E
    Antiviral Res; 1993 Sep; 22(1):45-75. PubMed ID: 8250543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemorrhagic fever viruses as biological weapons: medical and public health management.
    Borio L; Inglesby T; Peters CJ; Schmaljohn AL; Hughes JM; Jahrling PB; Ksiazek T; Johnson KM; Meyerhoff A; O'Toole T; Ascher MS; Bartlett J; Breman JG; Eitzen EM; Hamburg M; Hauer J; Henderson DA; Johnson RT; Kwik G; Layton M; Lillibridge S; Nabel GJ; Osterholm MT; Perl TM; Russell P; Tonat K;
    JAMA; 2002 May; 287(18):2391-405. PubMed ID: 11988060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-throughput screening for negative-stranded hemorrhagic fever viruses using reverse genetics.
    Wendt L; Bostedt L; Hoenen T; Groseth A
    Antiviral Res; 2019 Oct; 170():104569. PubMed ID: 31356830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recognition and management of bioterrorism infections.
    O'Brien KK; Higdon ML; Halverson JJ
    Am Fam Physician; 2003 May; 67(9):1927-34. PubMed ID: 12751654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenesis of arenavirus hemorrhagic fevers.
    Moraz ML; Kunz S
    Expert Rev Anti Infect Ther; 2011 Jan; 9(1):49-59. PubMed ID: 21171877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical aspects of bio-terrorism.
    Balali-Mood M; Moshiri M; Etemad L
    Toxicon; 2013 Jul; 69():131-42. PubMed ID: 23339855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An update on the development of drugs against smallpox.
    Tse-Dinh YC
    Curr Opin Investig Drugs; 2008 Aug; 9(8):865-70. PubMed ID: 18666034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anthrax, tularemia, plague, ebola or smallpox as agents of bioterrorism: recognition in the emergency room.
    Cunha BA
    Clin Microbiol Infect; 2002 Aug; 8(8):489-503. PubMed ID: 12197871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Haemorrhagic fever viruses, possible bioterrorist use].
    Rigaudeau S; Bricaire F; Bossi P
    Presse Med; 2005 Jan; 34(2 Pt 2):169-76. PubMed ID: 15687968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minigenomes, transcription and replication competent virus-like particles and beyond: reverse genetics systems for filoviruses and other negative stranded hemorrhagic fever viruses.
    Hoenen T; Groseth A; de Kok-Mercado F; Kuhn JH; Wahl-Jensen V
    Antiviral Res; 2011 Aug; 91(2):195-208. PubMed ID: 21699921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treating viral hemorrhagic fever.
    Mairuhu AT; Brandjes DP; van Gorp EC
    IDrugs; 2003 Nov; 6(11):1061-6. PubMed ID: 14600838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Animal models of viral hemorrhagic fever.
    Smith DR; Holbrook MR; Gowen BB
    Antiviral Res; 2014 Dec; 112():59-79. PubMed ID: 25448088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Research on prevention and treatment of hemorrhagic fevers.
    Joniec J; Kołodziej M; Bartoszcze M; Kocik J; Knap J
    Ann Agric Environ Med; 2012; 19(2):165-71. PubMed ID: 22742784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Viral hemorrhagic fever as a biological weapon].
    Robenshtok E; Laster M; Katz L; Brenner B; Sagi R
    Harefuah; 2002 May; 141 Spec No():96-9, 119. PubMed ID: 12170564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Confronting bioterrorism: physicians on the front line.
    Varkey P; Poland GA; Cockerill FR; Smith TF; Hagen PT
    Mayo Clin Proc; 2002 Jul; 77(7):661-72. PubMed ID: 12108604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antivirals and resistance: influenza virus.
    Ison MG
    Curr Opin Virol; 2011 Dec; 1(6):563-73. PubMed ID: 22440914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unique small molecule entry inhibitors of hemorrhagic fever arenaviruses.
    Lee AM; Rojek JM; Spiropoulou CF; Gundersen AT; Jin W; Shaginian A; York J; Nunberg JH; Boger DL; Oldstone MB; Kunz S
    J Biol Chem; 2008 Jul; 283(27):18734-42. PubMed ID: 18474596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.